West Pharmaceutical Servs Sees Q2 Sales $830.000M-$850.000M vs $818.537M Est
Benzinga Newsdesk 6 months ago
NewsGuidance
West Pharmaceutical Servs (NYSE:WST) sees Q2 sales of $830.000 million-$850.000 million vs $818.537 million analyst estimate.
West Pharmaceutical Servs (NYSE:WST) sees Q2 sales of $830.000 million-$850.000 million vs $818.537 million analyst estimate.